Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Caplyta (lumateperone) is a prescription medication used for the treatment of schizophrenia and depressive episodes associated with bipolar I or II disorder in adults.
Caplyta comes in 10.5 mg, 21 mg, and 42 mg capsules for oral administration.
Fact Table | |
---|---|
Formula | C24H28Cl2N4O2S |
License | FDA approved |
Bioavailability | Approximately 4.4% |
Legal status | Prescription only |
Chemical Name | 1-[4-[2-[4-(3-chlorophenyl)-1-piperazinyl]ethyl]phenyl]-4-methyl-1,2,3,6-tetrahydro-3-pyrrolo[1,2-a]pyrazin-5-one |
Elimination half-life | Approximately 13-20 hours |
Dosage (Strength) | 42 mg capsules |
Pregnancy | Consult a healthcare provider; not recommended |
Brands | Caplyta |
Protein binding | 97% |
PubChem CID | 11594410 |
MedlinePlus | a620003 |
ChEBI | 145372 |
ATC code | N05AX23 |
DrugBank | DB11978 |
KEGG | D10829 |
Routes of administration | Oral |
Caplyta should be taken as your healthcare provider has directed. Your healthcare provider will decide on a treatment plan that’s appropriate for you. Caplyta dosing will also be determined by your healthcare provider.
The medication guide that accompanies your prescription should be thoroughly read. Reach out to your healthcare provider or pharmacist about any questions or concerns you have about the medication.
Recommended dosing: Take 42 mg by mouth one time a day. The medication may be taken with or without food. A smaller dose (21 mg one time a day) is recommended for patients with moderate or severe liver problems.
Caplyta medication should be stored away from children and kept at room temperature (68°F to 77°F [20°C to 25°C]).
Lumateperone is the active ingredient in Caplyta.
Croscarmellose sodium, gelatin, magnesium stearate, mannitol, talc, FD&C blue #1 and red #3 (42 mg), FDA/E172 black iron oxide, FDA/E172 red iron oxide and FD&C red #3 (10.5 mg), and titanium dioxide (10.5 mg, 21 mg, and 42 mg) are the inactive ingredients included.
Patients who are allergic to lumateperone or to any of the other ingredients in Caplyta should not take it.
Caplyta side effects include but are not limited to sleepiness, sedation, dry mouth, dizziness, and nausea. Notify your healthcare provider right away if you have bothersome or persistent side effects.
Here, you can buy Caplyta!
Caplyta. New York, NY: Intra-Cellular Therapies, Inc.; 2023.